References
- Moradi K, Aznab M, Tahmasebi S, et al. The spectrum of α-thalassemia mutations in the Lak population of Iran. Hemoglobin. 2019;43(2):107–111.
- Nicholls R, Fischel-Ghodsian N, Higgs D. Recombination at the human α-globin gene cluster: sequence features and topological constraints. Cell. 1987;49(3):369–378.
- Brancaleoni V, Di Pierro E, Motta I, et al. Laboratory diagnosis of thalassemia. Int Jnl Lab Hem. 2016;38(Suppl 1):32–40.
- Harteveld CL, Higgs DR. α-Thalassaemia. Orphanet J Rare Dis. 2010;5:13.
- Valaei A, Karimipoor M, Kordafshari A, et al. Molecular basis of α-thalassemia in Iran. Iran Biomed J. 2018;22(1):6–14.
- Singh SA, Sarangi S, Appiah Kubi A, et al. Hb Adana (HBA2 or HBA1: c.179G>A) and α thalassemia: genotype-phenotype correlation. Pediatr Blood Cancer. 2018;65(9):e27220.
- Alibakhshi R, Mehrabi M, Omidniakan L, et al. The spectrum of α-thalassemia mutations in Kermanshah Province, West Iran. Hemoglobin. 2015;39(6):403–406.
- Alibakhshi R, Khalegi S, Akramipour R, et al. Molecular analysis of α globin genes non deletional mutations in α thalassemia patients in Kermanshah province. Razi J Med Sci. 2014;21(118):13–21.
- Mehrabi M, Alibakhshi R, Fathollahi S, et al. The spectrum of β-thalassemia mutations in Kermanshah Province in West Iran and its association with hematological parameters. Hemoglobin. 2013;37(6):544–552.
- Alibakhshi R, Moradi K, Aznab M, et al. The spectrum of β-thalassemia mutations in Hamadan Province, West Iran. Hemoglobin. 2019;43(1):18–22.
- Miri-Moghaddam E, Bahrami S, Naderi M, et al. Xmn1-158 γGvariant in B-thalassemia intermediate patients in South-East of Iran. Int J Hematol Oncol Stem Cell Res. 2017;11(2):165–171.
- Nainggolan IM, Harahap A, Ambarwati DD, et al. Interaction of Hb Adana (HBA2: c.179G>A) with deletional and nondeletional α(+)-thalassemia mutations: diverse hematological and clinical features. Hemoglobin. 2013;37(3):297–305.
- Çürük M, Dimovski A, Baysal E, et al. Hb Adana or α α259(E8)Gly→Aspβ2, a severely unstable α 1-globin variant, observed in combination with the –(α)20.5 Kb α-thal-1 deletion in two Turkish patients. Am J Hematol. 1993;44(4):270–275.
- Hamid M, Bokharaei H, Galehdari H, et al. A novel α-thalassemia nonsense mutation in HBA2: c.382A>T globin gene. Arch Iran Med. 2014;17(7):475–476.
- Alibakhshi R, Moradi K, Mohebbi Z, et al. Mutation analysis of PAH gene in patients with PKU in western Iran and its association with polymorphisms: identification of four novel mutations. Metab Brain Dis. 2014;29(1):131–138.
- Alibakhshi R, Moradi K, Biglari M, et al. Spectrum of phenylalanine hydroxylase gene mutations in Hamadan and Lorestan Provinces of Iran and their associations with variable number of tandem repeat alleles. Iran J Med Sci. 2018;43(3):318–323.
- Megawati D, Nainggolan IM, Swastika M, et al. Severe α-thalassemia intermedia due to a compound heterozygosity for the highly unstable Hb Adana (HBA2: c.179G>A) and a novel codon 24 (HBA2: c.75T>A) mutation. Hemoglobin. 2014;38(2):149–151.
- Lai Y, Chen Y, Chen B, et al. Genetic variants at BCL11A and HBS1L-MYB loci influence Hb F levels in Chinese Zhuang β-thalassemia intermedia patients. Hemoglobin. 2016;40(6):405–410.
- Cardoso GL, Diniz IG, da Silva A, et al. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil. Blood Cells Mol Dis. 2014;53(4):176–179.
- Durmaz AA, Akin H, Ekmekci AY, et al. A severe α thalassemia case compound heterozygous for Hb Adana in α1 gene and 20.5 kb double gene deletion. J Pediatr Hematol Oncol. 2009;31(8):592–594.
- Papassotiriou I, Traeger-Synodinos J, Vlachou C, et al. Rapid and accurate quantitation of Hb Bart's and Hb H using weak cation exchange high performance liquid chromatography: correlation with the α-thalassemia genotype. Hemoglobin. 1999;23(3):203–211.